Posted by Chantel Martiromo. research contributed by PubMed
Ina
study to compare the efficacy and safety of 2 dietary supplements
derived from red clover with placebo in symptomatic menopausal women,
posted in PubMed, indicated that of 252 participants, 246 (98%) completed the 12-week protocol. The
reductions in mean daily hot flash count at 12 weeks were similar for
the Promensil (5.1), Rimostil (5.4), and placebo (5.0) groups. In
comparison with the placebo group, participants in the Promensil group
(41%; 95% confidence interval [CI], 29%-51%; P =.03), but not in the
Rimostil group (34%; 95% CI, 22%-46%; P =.74) reduced hot flashes more
rapidly. Quality-of-life improvements and adverse events were comparable
in the 3 groups.
Chinese Secrets to Fatty Liver and Obesity Reversal
For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/
Does the supplement have side effects?
ReplyDeleteRed clover usually doesn’t cause very serious side effects when one takes the dose that is recommended by herbalist
ReplyDelete